Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - REVENUE
Revenue TVTX - Travere Therapeutics, Inc.
233 M
LAST VALUE
4.87%
2 YEAR CAGR
5.87%
5 YEAR CAGR
23.52%
10 YEAR CAGR